ASCL1 and neoplasm: To obtain a more definitive result, we also performed ATAC-seq analysis on an ASCL1+ PDX tumor that was homogeneously negative for FOXA2, in comparison to 3 ASCL1+/FOXA2+ PDX tumors (Fig. 6d, Supplementary Fig. 6f).